Skip to main content

"Undue Influence"

Karolinska Institutet dismissed Karl Tryggvason from his position in the office of Dean of Research because of "undue influence over how funds were allocated to leading professors at Karolinska Institutet," says this press release. After the institute announced in December how funds from its professors program were being distributed, some professors questioned how the selection process took place — it was supposed to be done by an independent evaluation committee — and a taskforce was deployed to look into the process. The inquiry found that Tryggvason sent a letter to the evaluation committee chair promoting who he wanted to receive the funds. "I take such unethical conduct very, very seriously and have therefore dismissed Karl Tryggvason from the office of Dean of Research with immediate effect," says Harriet Wallberg-Henriksson in a statement.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.